Kyahn Williamson

Investor relations professional @ Buchan. Covering med tech, healthcare and biotech and tech. Living and loving the crazy juggle of life with two little ones.

[WE Communications Australia Investor Relations @WEComms_AU_IR]

R&D Tax Incentive bill to be deferred until further examination - great outcome for local innovation and biotech companies led by @ausbiotech @MedicinesAus & @biomelb https://t.co/QhdNXbKCBz #ausbiotech #ausbiz

[Paul Smith @SaysSmithy]

Huge story this. One of Australia's hottest startups Unlockd has had to pull out of an imminent IPO to fight for survival after Google said it was banning its apps from the Play Store and AdMob (anti-competitive move?!) https://t.co/zulOCzuM26 #startupaus

[Rebecca Wilson @Beck_WEComms]

So proud of the wonderful team @BuchanWE and our amazing clients. We just won Agency of the Year @mumbrella #CommsCon

[Telix Pharmaceuticals @TelixPharma]

Telix Pharmaceuticals and Radboud University Medical Centre Conclude Clinical Collaboration Agreement https://t.co/KINSYp4CZ1

[Kyahn Williamson @KyahnKy]

@megmacmusic most amazing gig at #makinggravy ... brought tears to my eyes

[PRovoke Media @Provoke_News]

McDonald's Hands New Consumer Tech Brief To WE Communications https://t.co/2EvS6nXwv6

[Kyahn Williamson @KyahnKy]

@asxlongtail Sounds like an article I once read on a blog site

[Telix Pharmaceuticals @TelixPharma]

Nice Livewire write-up on Telix $TLX - Thanks for the Christmas Present!

https://t.co/DAs0PA0V65

[Rebecca Wilson @Beck_WEComms]

@BuchanIR @_SelfWealth Distruptor or enabler. Whatever you think the latest fintech to hit the @ASX @_SelfWealth is the hot talking point of broking and self directed investors. If you missed out on IPO jump in now.

[Trevor Hoey @TrevorHoey]

$VHT Clearance strengthens position in Taiwan 670,000 market. High breast cancer occurrence and use of detection tech. RBS target price 81c

[Factor Therapeutics @Factor_Tx]

Meet our new CEO. A punchy interview by @ScottPowerSays at @morgansAU. Welcome Dr. Wilson!

https://t.co/loXwiMGmHT @BuchanIR @Factor_Tx

[WE Communications Australia Investor Relations @WEComms_AU_IR]

As part of the $ASX CEO sessions, @Factor_Tx NED Dr Chris Behrenbruch discuses FTT's trials & future potential https://t.co/opkxg3RUQW $FTT

[WE Communications Australia Investor Relations @WEComms_AU_IR]

.@Finnewsnetwork discusses Visioneering Technologies Inc (ASX:VTI) recent #IPO w/ CEO Dr Stephen Snowdy https://t.co/VGpWkJZlbI #ASX $VTI

[Volpara Health @Volpara]

Women with dense breasts are 4–6 times more likely to develop breast cancer. Know your risk https://t.co/gfRVW8uSbk

[WE Communications Australia Investor Relations @WEComms_AU_IR]

Congratulations to the team at Reva Medical $RVA on achieving CE Mark for the Fantom bioresorbable coronary scaffold https://t.co/7m0ZaKPUV7

[WE Communications Australia Investor Relations @WEComms_AU_IR]

Visioneering Techonologies, Inc. lists on the ASX – Listing Ceremony https://t.co/bhHsdZZmwI

[MTPConnect @MTPConnect_AUS]

"Australia is already right up there and could be positioned at the front of the bus" #medtech #innovation https://t.co/TZYxs5fG74

[Rebecca Wilson @Beck_WEComms]

Heard the news? @WEcomms expanding its Asia presence with acquisition of #WATATAWA and #RedBridge. Welcome to the @WE_APAC family @BuchanWE

[Kyahn Williamson @KyahnKy]

@WE_APAC @BuchanWE congratulations... exciting news for our region

[WE Communications Australia Investor Relations @WEComms_AU_IR]

Great segment on our client @AirXpander on @CBS' medical TV show @TheDoctors https://t.co/ZfLufPh8p0 #ASX #AXP